PofoliaShared via Pofolia

Journal of Clinical Oncology· 2016Q1· Guideline

Management of Chronic Pain in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

Judith A. Paice, Russell K. Portenoy, Christina Lacchetti, Toby C. Campbell et al.

Short summary

Adult cancer survivors reporting new pain should be evaluated for recurrent disease, second malignancy, or late-onset treatment effects, and clinicians should screen for pain at every encounter.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Screen for pain at every patient encounter.
  • Evaluate new-onset pain in survivors for recurrent disease, second malignancy, or late treatment effects.
  • Consider non-opioid and adjuvant analgesics for pain relief and functional improvement.
  • Opioids may be trialed in carefully selected patients unresponsive to conservative management, with thorough risk assessment.

AI-generated from the title and abstract; the full text is not read.

Abstract

PURPOSE: To provide evidence-based guidance on the optimum management of chronic pain in adult cancer survivors. METHODS: An ASCO-convened expert panel conducted a systematic literature search of studies investigating chronic pain management in cancer survivors. Outcomes of interest included symptom relief, pain intensity, quality of life, functional outcomes, adverse events, misuse or diversion, and risk assessment or mitigation. RESULTS: A total of 63 studies met eligibility criteria and compose the evidentiary basis for the recommendations. Studies tended to be heterogeneous in terms of quality, size, and populations. Primary outcomes also varied across the studies, and in most cases, were not directly comparable because of different outcomes, measurements, and instruments used at different time points. Because of a paucity of high-quality evidence, many recommendations are based on expert consensus. RECOMMENDATIONS: Clinicians should screen for pain at each encounter. Recurrent disease, second malignancy, or late-onset treatment effects in any patient who reports new-onset pain should be evaluated, treated, and monitored. Clinicians should determine the need for other health professionals to provide comprehensive pain management care in patients with complex needs. Systemic nonopioid analgesics and adjuvant analgesics may be prescribed to relieve chronic pain and/or to improve function. Clinicians may prescribe a trial of opioids in carefully selected patients with cancer who do not respond to more conservative management and who continue to experience distress or functional impairment. Risks of adverse effects of opioids should be assessed. Clinicians should clearly understand terminology such as tolerance, dependence, abuse, and addiction as it relates to the use of opioids and should incorporate universal precautions to minimize abuse, addiction, and adverse consequences. Additional information is available at www.asco.org/chronic-pain-guideline and www.asco.org/guidelineswiki.

The authors' abstract, as published at the source. Journal of Clinical Oncology, 2016 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Anesthesiology and Pain Medicine

Anesthesiology and Pain MedicineMedicine